Cargando…

Long non-coding RNA CASC2 regulates osteoblasts matrix mineralization

Long non-coding RNAs (lncRNAs) are master regulators of gene expression and have recently emerged as potential innovative therapeutic targets. The deregulation of lncRNA expression patterns has been associated with age-related and noncommunicable diseases in the bone tissue, including osteoporosis a...

Descripción completa

Detalles Bibliográficos
Autores principales: Freitas, Jaime, Moura, Sara Reis, Barbosa, Mário Adolfo, Santos, Susana G., Almeida, Maria Inês
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353537/
https://www.ncbi.nlm.nih.gov/pubmed/37469450
http://dx.doi.org/10.3389/fbioe.2023.1155596
_version_ 1785074730847436800
author Freitas, Jaime
Moura, Sara Reis
Barbosa, Mário Adolfo
Santos, Susana G.
Almeida, Maria Inês
author_facet Freitas, Jaime
Moura, Sara Reis
Barbosa, Mário Adolfo
Santos, Susana G.
Almeida, Maria Inês
author_sort Freitas, Jaime
collection PubMed
description Long non-coding RNAs (lncRNAs) are master regulators of gene expression and have recently emerged as potential innovative therapeutic targets. The deregulation of lncRNA expression patterns has been associated with age-related and noncommunicable diseases in the bone tissue, including osteoporosis and tumors. However, the specific role of lncRNAs in physiological or pathological conditions in the bone tissue still needs to be further clarified, for their exploitation as therapeutic tools. In the present study, we evaluate the potential of the lncRNA CASC2 as a regulator of osteogenic differentiation and mineralization. Results show that CASC2 expression is decreased during osteogenic differentiation of human bone marrow-derived Mesenchymal Stem/Stromal cells (hMSCs). CASC2 knockdown, using small interfering RNA against CASC2 (siCASC2), increases the expression of the late osteogenic marker Bone Sialoprotein (BSP), but does not impact ALP staining level nor the expression of early osteogenic transcripts, including RUNX2 and OPG. Although siCASC2 does not impact hMSC proliferation nor apoptosis, it promotes the mineralization of hMSC cultured under osteogenic-inducing conditions, as shown by the increase of calcium deposits. Mass spectrometry-based proteomic analysis revealed that 89 proteins are regulated by CASC2 at late osteogenic stages, including proteins associated with bone diseases or anthropometric and musculoskeletal traits. Specifically, the Cartilage Oligomeric Matrix Protein (COMP) is highly enhanced by CASC2 knockdown at late stages of osteogenic differentiation, at both transcriptional and protein level. On the other hand, inhibition of COMP impairs osteoblasts mineralization as well as the expression of BSP. The results indicate that lncRNA CASC2 regulates late osteogenic differentiation and mineralization in hMSC via COMP and BSP. In conclusion, this study suggests that targeting lncRNA CASC2 could be a potential approach for modulating bone mineralization.
format Online
Article
Text
id pubmed-10353537
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103535372023-07-19 Long non-coding RNA CASC2 regulates osteoblasts matrix mineralization Freitas, Jaime Moura, Sara Reis Barbosa, Mário Adolfo Santos, Susana G. Almeida, Maria Inês Front Bioeng Biotechnol Bioengineering and Biotechnology Long non-coding RNAs (lncRNAs) are master regulators of gene expression and have recently emerged as potential innovative therapeutic targets. The deregulation of lncRNA expression patterns has been associated with age-related and noncommunicable diseases in the bone tissue, including osteoporosis and tumors. However, the specific role of lncRNAs in physiological or pathological conditions in the bone tissue still needs to be further clarified, for their exploitation as therapeutic tools. In the present study, we evaluate the potential of the lncRNA CASC2 as a regulator of osteogenic differentiation and mineralization. Results show that CASC2 expression is decreased during osteogenic differentiation of human bone marrow-derived Mesenchymal Stem/Stromal cells (hMSCs). CASC2 knockdown, using small interfering RNA against CASC2 (siCASC2), increases the expression of the late osteogenic marker Bone Sialoprotein (BSP), but does not impact ALP staining level nor the expression of early osteogenic transcripts, including RUNX2 and OPG. Although siCASC2 does not impact hMSC proliferation nor apoptosis, it promotes the mineralization of hMSC cultured under osteogenic-inducing conditions, as shown by the increase of calcium deposits. Mass spectrometry-based proteomic analysis revealed that 89 proteins are regulated by CASC2 at late osteogenic stages, including proteins associated with bone diseases or anthropometric and musculoskeletal traits. Specifically, the Cartilage Oligomeric Matrix Protein (COMP) is highly enhanced by CASC2 knockdown at late stages of osteogenic differentiation, at both transcriptional and protein level. On the other hand, inhibition of COMP impairs osteoblasts mineralization as well as the expression of BSP. The results indicate that lncRNA CASC2 regulates late osteogenic differentiation and mineralization in hMSC via COMP and BSP. In conclusion, this study suggests that targeting lncRNA CASC2 could be a potential approach for modulating bone mineralization. Frontiers Media S.A. 2023-07-04 /pmc/articles/PMC10353537/ /pubmed/37469450 http://dx.doi.org/10.3389/fbioe.2023.1155596 Text en Copyright © 2023 Freitas, Moura, Barbosa, Santos and Almeida. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Freitas, Jaime
Moura, Sara Reis
Barbosa, Mário Adolfo
Santos, Susana G.
Almeida, Maria Inês
Long non-coding RNA CASC2 regulates osteoblasts matrix mineralization
title Long non-coding RNA CASC2 regulates osteoblasts matrix mineralization
title_full Long non-coding RNA CASC2 regulates osteoblasts matrix mineralization
title_fullStr Long non-coding RNA CASC2 regulates osteoblasts matrix mineralization
title_full_unstemmed Long non-coding RNA CASC2 regulates osteoblasts matrix mineralization
title_short Long non-coding RNA CASC2 regulates osteoblasts matrix mineralization
title_sort long non-coding rna casc2 regulates osteoblasts matrix mineralization
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353537/
https://www.ncbi.nlm.nih.gov/pubmed/37469450
http://dx.doi.org/10.3389/fbioe.2023.1155596
work_keys_str_mv AT freitasjaime longnoncodingrnacasc2regulatesosteoblastsmatrixmineralization
AT mourasarareis longnoncodingrnacasc2regulatesosteoblastsmatrixmineralization
AT barbosamarioadolfo longnoncodingrnacasc2regulatesosteoblastsmatrixmineralization
AT santossusanag longnoncodingrnacasc2regulatesosteoblastsmatrixmineralization
AT almeidamariaines longnoncodingrnacasc2regulatesosteoblastsmatrixmineralization